Catheter ablation for atrial fibrillation (AF) in patients with tachycardia‐bradycardia syndrome (TBS) can be a major therapeutic option to replace permanent pacemaker implantation (PMI). However, the very long‐term outcome of… Click to show full abstract
Catheter ablation for atrial fibrillation (AF) in patients with tachycardia‐bradycardia syndrome (TBS) can be a major therapeutic option to replace permanent pacemaker implantation (PMI). However, the very long‐term outcome of more than 15 years in these patients has not been elucidated.
               
Click one of the above tabs to view related content.